An effective vaccine to protect against the Mers virus is a step closer,european scientists genetically modified a version of the smallpox vaccine to display Mers virus protein on its surface.
The vaccine was able to protect camels - the animal reservoir for the virus - from developing Mers virus symptoms. Experts hope the vaccine might stop the virus spreading in camels and may also protect humans at risk from infection.
Infections have been reported in 26 countries around the world with the outbreak epi-centre located in the Arabian Peninsula.There are no treatments for Mers but scientists are trying to develop an effective vaccine. One such scientist is Prof Bart Haagmans, who is based at the Erasmus Medical Centre in the Netherlands. He has been busy developing and testing vaccines in camels.
A team of scientists drawn from the Netherlands, Spain and Germany, genetically engineered a pox virus called Modified Vaccinia Ankara -MVA - to display Mers virus spike protein on its surface. MVA, related to the virus used to eradicate smallpox, was used to eradicate smallpox and is currently being used to develop vaccines to a variety of viruses like influenza, Ebola and hepatitis C. Importantly it can produce antibodies and killer cells.The Mers spike protein is thought to be a major target for the immune response. The team hoped that by cloaking MVA with this spike they would train the immune system to recognize and kill Mers.
The team took the engineered MVA, sprayed it up the noses of camels and injected it into their muscle, and then four weeks later they repeated the vaccination again.
When the team exposed the vaccinated animals to the Mers virus the camels developed very mild symptoms. Crucially they didn't develop a runny nose and the amount of virus they produced was very low.
Camels that hadn't received the vaccine produced very large amounts of virus and suffered a very runny nose. This indicates that even though the vaccine didn't prevent infection it did reduce the amount of virus that the vaccinated camels produced.
story credit BBC news.
Agribusiness, Agriculture, Veterinary Medicine, Cassava, Garri, food security, Agritech and the Red Meat Value Chain.
Showing posts with label immune response. Show all posts
Showing posts with label immune response. Show all posts
Tuesday, December 22, 2015
MERS VACCINE !!!
An effective vaccine to protect against the Mers virus is a step closer,european scientists genetically modified a version of the smallpox vaccine to display Mers virus protein on its surface.
The vaccine was able to protect camels - the animal reservoir for the virus - from developing Mers virus symptoms. Experts hope the vaccine might stop the virus spreading in camels and may also protect humans at risk from infection.
Infections have been reported in 26 countries around the world with the outbreak epi-centre located in the Arabian Peninsula.There are no treatments for Mers but scientists are trying to develop an effective vaccine. One such scientist is Prof Bart Haagmans, who is based at the Erasmus Medical Centre in the Netherlands. He has been busy developing and testing vaccines in camels.
A team of scientists drawn from the Netherlands, Spain and Germany, genetically engineered a pox virus called Modified Vaccinia Ankara -MVA - to display Mers virus spike protein on its surface. MVA, related to the virus used to eradicate smallpox, was used to eradicate smallpox and is currently being used to develop vaccines to a variety of viruses like influenza, Ebola and hepatitis C. Importantly it can produce antibodies and killer cells.The Mers spike protein is thought to be a major target for the immune response. The team hoped that by cloaking MVA with this spike they would train the immune system to recognize and kill Mers.
The team took the engineered MVA, sprayed it up the noses of camels and injected it into their muscle, and then four weeks later they repeated the vaccination again.
When the team exposed the vaccinated animals to the Mers virus the camels developed very mild symptoms. Crucially they didn't develop a runny nose and the amount of virus they produced was very low.
Camels that hadn't received the vaccine produced very large amounts of virus and suffered a very runny nose. This indicates that even though the vaccine didn't prevent infection it did reduce the amount of virus that the vaccinated camels produced.
story credit BBC news.
Subscribe to:
Comments (Atom)
Agribusiness ideas.
Popular Posts
-
Diabetes mellitus is a condition where the cells of the body cannot metabolize the glucose from the blood this results in rise in blood ...
-
Meat and poultry are among the leading vehicles for foodborne illnesses around the world and are responsible for sickening million of peop...
-
Cattle infected with bovine tuberculosis are spreading infections to humans by the following routes ;eating unpasteurized milk produc...
-
BIO-SECURITY,is basically keeping germs out of your production site.There are so many agents that are used but i want to talk about the us...
-
A new farm management tool has been launched to help farmers track and monitor their money and provide data quickly to their accountant. C...
-
UN WOMEN. There are 1.1 billion girls in the world, and every one of them deserves equal opportunities for a better future. They are a sour...
AGRIBUSINESS EDUCATION.
Translate
I-CONNECT -AGRICULTURE
AGRIBUSINESS TIPS.
AGRIBUSINESS.
The Agriculture Daily
veterinarymedicineechbeebolanle-ojuri.blogspot.com Cassava: benefits of garri as a fermented food. Cassava processing involves fermentation which is a plus for gut health. The fermentation process removes the cyanogenic glucosides present in the fres...